Gotham Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Buy
16,175
+4,867
+43% +$4.93M 0.05% 559
2025
Q4
$12.2M Buy
11,308
+3,292
+41% +$3.15M 0.04% 576
2025
Q3
$6.12M Buy
8,016
+830
+12% +$618K 0.03% 718
2025
Q2
$5.6M Sell
7,186
-361
-5% -$281K 0.03% 635
2025
Q1
$6.23M Buy
7,547
+1,768
+31% +$1.47M 0.05% 482
2024
Q4
$4.46M Sell
5,779
-2,736
-32% -$2.27M 0.04% 532
2024
Q3
$7.54M Sell
8,515
-3,434
-29% -$3.09M 0.08% 372
2024
Q2
$10.8M Buy
11,949
+2,065
+21% +$1.65M 0.14% 159
2024
Q1
$7.69M Buy
9,884
+620
+7% +$441K 0.12% 220
2023
Q4
$5.4M Buy
9,264
+1,878
+25% +$1.1M 0.1% 266
2023
Q3
$3.97M Buy
7,386
+3,891
+111% +$2.01M 0.08% 343
2023
Q2
$1.64M Sell
3,495
-224
-6% -$93.9K 0.04% 608
2023
Q1
$1.28M Buy
3,719
+42
+1% +$14.2K 0.03% 668
2022
Q4
$1.35M Buy
3,677
+58
+2% +$20.6K 0.04% 577
2022
Q3
$1.17M Buy
3,619
+198
+6% +$62.7K 0.04% 597
2022
Q2
$1.11M Buy
3,421
+81
+2% +$24.3K 0.04% 541
2022
Q1
$956K Buy
3,340
+814
+32% +$209K 0.03% 575
2021
Q4
$698K Sell
2,526
-31,213
-93% -$7.91M 0.02% 651
2021
Q3
$7.79M Buy
33,739
+31,854
+1,690% +$7.86M 0.32% 69
2021
Q2
$433K Sell
1,885
-1,667
-47% -$335K 0.02% 728
2021
Q1
$664K Buy
+3,552
New +$695K 0.03% 602
2019
Q4
Sell
-105,655
Closed -$11.8M 1166
2019
Q3
$11.8M Sell
105,655
-397,920
-79% -$44.3M 0.21% 132
2019
Q2
$55.8M Buy
503,575
+257,782
+105% +$30.4M 0.89% 9
2019
Q1
$31.9M Sell
245,793
-66,667
-21% -$8.11M 0.47% 45
2018
Q4
$36.2M Buy
312,460
+242,632
+347% +$27.1M 0.56% 28
2018
Q3
$7.49M Buy
+69,828
New +$6.98M 0.1% 271
2018
Q2
Sell
-90,625
Closed -$7.01M 966
2018
Q1
$7.01M Sell
90,625
-165,912
-65% -$13.4M 0.1% 297
2017
Q4
$21.7M Buy
+256,537
New +$21.8M 0.31% 95
2017
Q3
Sell
-8,999
Closed -$741K 983
2017
Q2
$741K Sell
8,999
-439,592
-98% -$35.9M 0.01% 683
2017
Q1
$37.7M Buy
448,591
+410,286
+1,071% +$32.9M 0.48% 30
2016
Q4
$2.82M Buy
+38,305
New +$2.85M 0.04% 463
2015
Q1
Sell
-5,634
Closed -$389K 972
2014
Q4
$389K Buy
5,634
+6
+0.1% +$405 ﹤0.01% 781
2014
Q3
$365K Sell
5,628
-2,121
-27% -$134K ﹤0.01% 818
2014
Q2
$482K Sell
7,749
-1,267
-14% -$75.6K 0.01% 791
2014
Q1
$531K Sell
9,016
-132,105
-94% -$7.37M 0.01% 779
2013
Q4
$7.2M Buy
141,121
+94,360
+202% +$4.73M 0.17% 194
2013
Q3
$2.35M Buy
46,761
+7,350
+19% +$385K 0.08% 389
2013
Q2
$1.94M Buy
+39,411
New +$2.14M 0.08% 369

Other funds holding LLY

Gotham Asset Management's LLY Position: Q1 2026 in Review

Gotham Asset Management increased its Eli Lilly (LLY) stake by 43% in Q1 2026, buying an estimated $4.93M and bringing the position to 16,175 shares worth $14.9M. The position accounts for 0.05% of the portfolio, ranked #559.

Gotham Asset Management first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $55.8M in Q2 2019. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gotham Asset Management held 16,175 shares of Eli Lilly worth $14.9M as of Q1 2026.
  • Gotham Asset Management bought 4,867 Eli Lilly shares in Q1 2026, an estimated $4.93M.
  • Eli Lilly made up 0.05% of Gotham Asset Management's portfolio in Q1 2026, its #559 holding.
  • Gotham Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
  • Gotham Asset Management's Eli Lilly position peaked at $55.8M in Q2 2019.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.